Published in

Elsevier, Journal of the American College of Cardiology, 11(75), p. 75, 2020

DOI: 10.1016/s0735-1097(20)30702-6

Links

Tools

Export citation

Search in Google Scholar

Apolipoprotein B, Pcsk9 Inhibition With Alirocumab, and Ischemic Cardiovascular Events After Acute Coronary Syndrome: Insights From the Odyssey Outcomes Trial

Journal article published in 2020 by Emil Hagstrom, Philippe Gabriel Steg, Michael Szarek, Deepak Bhatt, Vera Bittner, Nicolas Danchin, Rafael Diaz, Shaun Goodman, Robert A. Harrington, Johan Wouter Jukema, Yong-Un Kim, Evangelos Liberopoulos, Nikolaus Marx, Jennifer McGinniss, Matthew Roe and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO